ACRI Insider Trading Activity and SEC Form 4 Filings
ACRI insider trading summary
No open-market insider purchases or sales of Acacia Research Corp (ACRI) have been reported on SEC Form 4 in the past 12 months.
Latest ACRI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 26, 2016 | G Louis Graziadio III | Director | Buy | $46K (10,000 @ $4.57) |
| Mar 12, 2010 | Gabby Klausner | CFO | Sell | $8K (75,000 @ $0.10) |
| May 21, 2008 | Gabby Klausner | CFO | Buy | $7K (75,000 @ $0.09) |
| Jan 3, 2008 | Gadi Aner | CEO | Buy | $650 (10,000 @ $0.07) |
| Jan 3, 2008 | Gadi Aner | CEO | Buy | $3K (42,857 @ $0.07) |
| Dec 31, 2007 | Gadi Aner | CEO | Buy | $4K (68,000 @ $0.06) |
| Nov 5, 2007 | Ehud Keinan | Director | Buy | $3K (25,000 @ $0.10) |
| Nov 5, 2007 | Biotech Knowledge LLC | 10% Owner | Buy | $2K (25,000 @ $0.10) |
| Nov 5, 2007 | Ehud Keinan | Director | Buy | $2K (25,000 @ $0.10) |
| Nov 5, 2007 | Biotech Knowledge LLC | 10% Owner | Buy | $3K (25,000 @ $0.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.